A growing number corporate legal departments, including those at large pharmaceutical companies, are bringing artificial intelligence-powered contract review and analytics technology in-house to streamline much of their contracting work.

But one pharmaceutical executive is betting that the use of such technology still has yet to fully take off in the corporate world. And he’s moving to AI contract review provider Seal Software to prove it.